In the present study, we evaluated mRNA expression patterns of the mitotic kinases Nek2, Mps1/TTK, and TBK1, as well as the expression and association of these proteins with biomarkers of proliferation (Ki67) and EMT (E-cadherin and Vimentin) by using a novel breast cancer TMA. This evidence concerns the gene VIM and breast carcinoma.